Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa

Benjamin Davido(Assistance Publique – Hôpitaux de Paris), Lesly Fellous(Assistance Publique – Hôpitaux de Paris), Christine Lawrence(Assistance Publique – Hôpitaux de Paris), Virginie Maxime(Assistance Publique – Hôpitaux de Paris), Martin Rottman(Inserm), Aurélien Dinh(Assistance Publique – Hôpitaux de Paris)
Antimicrobial Agents and Chemotherapy
June 20, 2017
10.1128/aac.01008-17
Cited by 159Open Access
Full Text

Abstract

We have read with great interest the report by Marshall et al. regarding the efficacy of the combination of ceftazidime-avibactam (CAZ-AVI) and aztreonam (ATM) against metallo-β-lactamase-producing Enterobacteriaceae ([1][1]). These results confirm our experience with two patients treated with CAZ

Related Papers

No related papers found

Powered by citation graph analysis